
|Articles|March 15, 2003
FDA seeks innovation, shorter review process
Washington, DC-The FDA is proposing a set of guidelines geared toward improving the development and availability of new drugs and medical devices.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA extends Aldeyra's reproxalap PDUFA after requesting additional clinical study report
2
Spotlight on women's health: Understanding thyroid eye disease
3
Aviceda Therapeutics reports positive phase 2b SIGLEC results for AVD-104 in geographic atrophy
4
Strategic approaches optimize teaching and learning in the clinic
5









































